Casma Therapeutics to Present at the Keystone Symposia on Tumor Metabolism

CAMBRIDGE, Mass., February 12, 2024 – Casma Therapeutics, Inc., a biotechnology company engaging the autophagy/lysosomal system to provide innovative new medicines, today announced that Leon Murphy, Ph.D., Chief Scientific Officer, will present at the Keystone Meeting on Tumor Metabolism in Banff, Alberta, Canada, in the “Targeting Metabolism” Section. The title of Dr. Murphy’s talk is […] The post Casma Therapeutics to Present at the Keystone Symposia on Tumor Metabolism appeared first on Casma Therapeutics .